Inhibition of proliferation of human leukaemia 60 cells by methylglyoxal in vitro
- PMID: 8501967
- DOI: 10.1016/0145-2126(93)90094-2
Inhibition of proliferation of human leukaemia 60 cells by methylglyoxal in vitro
Abstract
Methylglyoxal (2-oxopropanal) is the physiological substrate of the glyoxalase system. When exogenous methylglyoxal (50 microM-1 mM) was added to human leukaemia 60 (HL60) cells in culture (5 x 10(4) cells/ml), inhibition of growth and toxicity was induced. The median growth inhibitory concentration IC50 value was 238 +/- 2 microM. There was little differentiation of HL60 cells induced by methylglyoxal (a maximum of 2% differentiation with 500 microM methylglyoxal). There was no similar toxicity induced by methylglyoxal in corresponding differentiated cells, neutrophils, under the same culture conditions. Cell growth and toxicity induced by methylglyoxal (250 microM) in HL60 cells occurred in the initial 24 h of culture, after which residual surviving cells exhibited normal growth kinetics. It could also be prevented by replacing the culture medium in the initial 6 h of culture; thereafter, irreversible toxicity developed, reaching the maximum value after 24 h of culture. Growth arrest and toxicity induced by methylglyoxal increased with increasing serum composition of the medium. The mechanism of toxicity is unknown.
Similar articles
-
Characteristics of the inhibition of human promyelocytic leukaemia HL60 cell growth by S-D-lactoylglutathione in vitro.Leuk Res. 1993 Apr;17(4):305-10. doi: 10.1016/0145-2126(93)90017-f. Leuk Res. 1993. PMID: 8487580
-
Inhibition of proliferation of human promyelocytic leukaemia HL60 cells by S-D-lactoylglutathione in vitro.Leuk Res. 1988;12(11-12):897-904. doi: 10.1016/0145-2126(88)90016-1. Leuk Res. 1988. PMID: 2905755
-
Inhibition of proliferation of human leukaemia 60 cells by methylglyoxal in vitro.Biochem Soc Trans. 1993 May;21(2):168S. doi: 10.1042/bst021168s. Biochem Soc Trans. 1993. PMID: 8359421 No abstract available.
-
Cells producing their own nemesis: understanding methylglyoxal metabolism.IUBMB Life. 2014 Oct;66(10):667-78. doi: 10.1002/iub.1324. Epub 2014 Nov 7. IUBMB Life. 2014. PMID: 25380137 Review.
-
Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification--a role in pathogenesis and antiproliferative chemotherapy.Gen Pharmacol. 1996 Jun;27(4):565-73. doi: 10.1016/0306-3623(95)02054-3. Gen Pharmacol. 1996. PMID: 8853285 Review.
Cited by
-
Methylglyoxal and Its Adducts: Induction, Repair, and Association with Disease.Chem Res Toxicol. 2022 Oct 17;35(10):1720-1746. doi: 10.1021/acs.chemrestox.2c00160. Epub 2022 Oct 5. Chem Res Toxicol. 2022. PMID: 36197742 Free PMC article. Review.
-
A trypanothione-dependent glyoxalase I with a prokaryotic ancestry in Leishmania major.Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13186-91. doi: 10.1073/pnas.0402918101. Epub 2004 Aug 25. Proc Natl Acad Sci U S A. 2004. PMID: 15329410 Free PMC article.
-
Molecular Assessment of Methylglyoxal-Induced Toxicity and Therapeutic Approaches in Various Diseases: Exploring the Interplay with the Glyoxalase System.Life (Basel). 2024 Feb 17;14(2):263. doi: 10.3390/life14020263. Life (Basel). 2024. PMID: 38398772 Free PMC article. Review.
-
Toxic concentrations of exogenously supplied methylglyoxal in hybridoma cell culture.Cytotechnology. 2004 Oct;46(2-3):97-107. doi: 10.1007/s10616-005-0301-5. Epub 2005 Nov 30. Cytotechnology. 2004. PMID: 19003265 Free PMC article.
-
Dual roles of methylglyoxal in cancer.Front Oncol. 2025 Apr 25;15:1557162. doi: 10.3389/fonc.2025.1557162. eCollection 2025. Front Oncol. 2025. PMID: 40352588 Free PMC article. Review.